Last reviewed · How we verify
Epoetin alfa and Darbepoetin alfa — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Epoetin alfa and Darbepoetin alfa (Epoetin alfa and Darbepoetin alfa) — Ortho Biotech Products, L.P..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Epoetin alfa and Darbepoetin alfa TARGET | Epoetin alfa and Darbepoetin alfa | Ortho Biotech Products, L.P. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Epoetin alfa and Darbepoetin alfa CI watch — RSS
- Epoetin alfa and Darbepoetin alfa CI watch — Atom
- Epoetin alfa and Darbepoetin alfa CI watch — JSON
- Epoetin alfa and Darbepoetin alfa alone — RSS
Cite this brief
Drug Landscape (2026). Epoetin alfa and Darbepoetin alfa — Competitive Intelligence Brief. https://druglandscape.com/ci/epoetin-alfa-and-darbepoetin-alfa. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab